Fundraising Fox
Solve, Inc.
1 known investors
Find your way into Solve, Inc.
QuartzBio provides a conversational AI platform that enables clinical-stage biopharma teams to gain real-time insights from fragmented sample, clinical, and biomarker data across their entire lifecycle. The platform uses domain-specific AI agents to transform data into actionable intelligence for pharmaceutical and biotechnology companies.
Investors · 1
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $251.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $223.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Solve, Inc. do?
- QuartzBio provides a conversational AI platform that enables clinical-stage biopharma teams to gain real-time insights from fragmented sample, clinical, and biomarker data across their entire lifecycle. The platform uses domain-specific AI agents to transform data into actionable intelligence for pharmaceutical and biotechnology companies.
- Who are Solve, Inc.'s investors?
- Solve, Inc.'s investors include Nat Turner.